Intellia Therapeutics Inc (0JBU)
LSE
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -16.601 | -20.007 | -23.59 | -29.206 | -26.565 | -27.186 | -33.695 | -34.114 |
Return on Equity (%) | -33.54 | -26.465 | -29.504 | -36.339 | -33.686 | -34.185 | -41.672 | -42.104 |
Return on Invested Capital (%) | -35.773 | -27.975 | -32.047 | -39.774 | -34.819 | -47.327 | -54.932 | -53.388 |
Operating Margin (%) | -191.966 | -258.617 | -280.42 | -230.919 | -231.457 | -810.492 | -909.779 | -1326.511 |
Net Profit Margin (%) | -191.966 | -258.617 | -280.42 | -230.919 | -231.457 | -810.492 | -909.779 | -1326.511 |
Book Value Per Share | 5.826 | 7.092 | 6.145 | 5.376 | 7.958 | 13.966 | 14.185 | 11.727 |
Earnings Per Share | -0.878 | -1.594 | -1.887 | -1.983 | -2.027 | -3.597 | -5.444 | -5.373 |
Cash Per Share | 7.581 | 8.038 | 1.301 | 1.14 | 2.416 | 1.657 | 6.01 | 2.532 |
Working Capital Per Share | 6.957 | 7.632 | 6.289 | 5.057 | 8.338 | 8.639 | 12.517 | 9.861 |
Operating Profit Per Share | 0.458 | 0.616 | 0.673 | 0.859 | 0.876 | 0.444 | 0.598 | 0.405 |
EBIT Per Share | -0.878 | -1.594 | -1.887 | -1.983 | -2.027 | -3.597 | -5.444 | -5.373 |
EBITDA Per Share | -0.878 | -1.594 | -1.887 | -1.983 | -2.027 | -3.597 | -5.444 | -5.373 |
Free Cash Flow Per Share | -0.738 | -1.426 | -1.845 | -1.959 | -2.068 | -3.518 | -5.375 | -5.317 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 36,02M | 42,39M | 45,22M | 50,2M | 66,23M | 74,49M | 87,1M | N/A |
Capitalisation boursière | 2,18B |
Ratio cours/bénéfice | -2,62 |
Ratio prix/ventes | 34,81 |
Ratio prix/liquidités | 5,57 |
Ratio prix/valeur comptable | 1,2 |
Rendement de dividende | - |
Actions en circulation | 89,56M |
Volume moyen (1 semaine) | 6,77k |
Volume moyen (1 mois) | 13,03k |
Variation sur 52 semaines | 0,00% |
Plus haut sur 52 semaines | 24,34 |
Plus bas sur 52 semaines | 24,34 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales